The American Hospital Association has called on federal regulators to intervene after Eli Lilly sent warning letters to 340B hospitals threatening to cut off discounted drug pricing unless they submit ...

The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...

The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that ...

In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...

AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount program with a lawsuit that challenges the definition of what it means to be a ...

While it may be hard to believe, there is one issue in Washington that meets the above criteria: fixing the 340B program.

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

On the heels of multiple lawsuits disrupting drug manufacturers’ efforts to convert the 340B Program into a rebate-based model, the Health Resources and Services Administration (HRSA) released a ...

President Donald Trump has repeatedly vowed to “cut waste, fraud and abuse everywhere that we can find it.” Congressional ...

Indiana officials are right to scrutinize how taxpayer dollars are spent, but when it comes to the proposed elimination of the federal 340B drug discount program, the state needs to be cautious. The ...

PHILADELPHIA, PA, UNITED STATES, February 4, 2026 /EINPresswire.com/ — RxParadigm, an end-to-end 340B drug administration platform with integrated capabilities to ...